Our experiments revealed high analytical sensitivity and specificity for both tests, suggesting that they could serve as reliable diagnostic tools to detect the JAK2 V617F mutation in the diagnosis of MPN. The gene discussed is JAK2; the disease is myeloproliferative disorder.